# A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center

> **NCT06949241** · — · ACTIVE_NOT_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 76 (actual)

## Conditions studied

- Pemphigus Disease
- Rituximab (RTx)
- Intravenous Immunoglobulin

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06949241
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-12-01
- **Primary completion:** 2026-02-02
- **Final completion:** 2026-02-02
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06949241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06949241, "A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06949241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*